Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Sep 10;297(6649):643-6.
doi: 10.1136/bmj.297.6649.643.

Langerhans' cells and subtypes of human papillomavirus in cervical intraepithelial neoplasia

Affiliations

Langerhans' cells and subtypes of human papillomavirus in cervical intraepithelial neoplasia

R J Hawthorn et al. BMJ. .

Abstract

There is strong circumstantial evidence that human papillomavirus is a cofactor in the development of cervical neoplasia. Systemic immunosuppression has also been implicated. A study was therefore carried out examining the relation between subtypes of human papillomavirus and local immunocompetent cells in the cervix. Colposcopically directed punch biopsy specimens were taken from normal cervix and from histologically proved cervical intraepithelial neoplasia for immunohistochemical studies. Human papillomavirus genome probing was performed on the abnormal specimens. A relation was apparent between decreased Langerhans' cells and moderate to high copy numbers of human papillomavirus type 16. The reduction in Langerhans' cells was significant for human papillomavirus type 18 even at low copy numbers. Conversely, the absence of human papillomavirus was associated with increased numbers of Langerhans' cells in cervical intraepithelial neoplasia. These findings suggest that the proposed oncogenic potential of human papillomavirus type 16 and human papillomavirus type 18 in particular may be mediated by a specific effect on the afferent limb of the immune response.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Exp Immunol. 1976 Dec;26(3):419-24 - PubMed
    1. Br Med J (Clin Res Ed). 1988 Feb 6;296(6619):381-5 - PubMed
    1. J Exp Med. 1982 Dec 1;156(6):1665-76 - PubMed
    1. Lancet. 1982 Dec 18;2(8312):1370-2 - PubMed
    1. Proc Natl Acad Sci U S A. 1983 Jan;80(2):560-3 - PubMed

Publication types